Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cell biomarker and beyond.

MLA

Soleimani, Atena, et al. “Emerging Roles of CD133 in the Treatment of Gastric Cancer, a Novel Stem Cell Biomarker and Beyond.” Life Sciences, vol. 293, Mar. 2022, p. 120050. EBSCOhost, https://doi.org/10.1016/j.lfs.2021.120050.

APA

Soleimani, A., Dadjoo, P., Avan, A., Soleimanpour, S., Rajabian, M., Ferns, G., Ryzhikov, M., Khazaei, M., & Hassanian, S. M. (2022). Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cell biomarker and beyond. Life Sciences, 293, 120050. https://doi.org/10.1016/j.lfs.2021.120050

Chicago

Soleimani, Atena, Parisa Dadjoo, Amir Avan, Saman Soleimanpour, Majid Rajabian, Gordon Ferns, Mikhail Ryzhikov, Majid Khazaei, and Seyed Mahdi Hassanian. 2022. “Emerging Roles of CD133 in the Treatment of Gastric Cancer, a Novel Stem Cell Biomarker and Beyond.” Life Sciences 293 (March): 120050. doi:10.1016/j.lfs.2021.120050.